Your browser doesn't support javascript.
loading
Phenotype of limited cutaneous systemic sclerosis patients with positive anti-topoisomerase I antibodies: data from the EUSTAR cohort.
Zanatta, Elisabetta; Huscher, Dörte; Ortolan, Augusta; Avouac, Jérôme; Airò, Paolo; Balbir-Gurman, Alexandra; Siegert, Elise; Matucci Cerinic, Marco; Cozzi, Franco; Riemekasten, Gabriela; Hoffmann-Vold, Anna-Maria; Distler, Oliver; Gabrielli, Armando; Heitmann, Stefan; Hunzelmann, Nicolas; Montecucco, Carlomaurizio; Morovic-Vergles, Jadranka; Ribi, Camillo; Doria, Andrea; Allanore, Yannick.
Afiliação
  • Zanatta E; Rheumatology Unit, Department of Medicine, University of Padova, Padova, Italy.
  • Huscher D; Institute of Biometry and Clinical Epidemiology and Berlin Institute of Health, Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Ortolan A; Rheumatology Unit, Department of Medicine, University of Padova, Padova, Italy.
  • Avouac J; Service de Rhumatologie, Hôpital Cochin, APHP, Université Paris Descartes, Paris, France.
  • Airò P; Rheumatology and Clinical Immunology, Spedali Civili, Brescia, Italy.
  • Balbir-Gurman A; B. Shine Rheumatology Institute Rambam Health Care Campus, Rappaport Faculty of Medicine, Technion, Haifa, Israel.
  • Siegert E; Department of Rheumatology and Clinical Immunology, Charité-Universitatsmedizin Berlin, Berlin, Germany.
  • Matucci Cerinic M; Department of Experimental and Clinical Medicine, Division of Rheumatology, University of Florence, Florence.
  • Cozzi F; Internal Medicine Unit, Ospedale Classificato Villa Salus, Venice, Italy.
  • Riemekasten G; Department of Rheumatology, Universitatsklinikum Schleswig Holstein-Campus Lübeck, Lübeck, Germany.
  • Hoffmann-Vold AM; Department of Rheumatology, Oslo University Hospital, Oslo, Norway.
  • Distler O; Department of Rheumatology, University Hospital Zürich, University of Zürich, Zürich, Switzerland.
  • Gabrielli A; Department of Clinical and Molecular Sciences, Università Politecnica Delle Marche, Ancona, Italy.
  • Heitmann S; Department of Rheumatology, Marienhospital Stuttgart, Stuttgart.
  • Hunzelmann N; Department of Dermatology, University of Cologne, Köln, Nordrhein-Westfalen, Germany.
  • Montecucco C; Department of Rheumatology, IRCCS Policlinico San Matteo Foundation, Pavia, Italy.
  • Morovic-Vergles J; Division of Clinical Immunology, Allergology and Rheumatology, Department of Internal Medicine, Dubrava University Hospital, Zagreb, Croatia.
  • Ribi C; Service d'immunologie et Allergie, Département de Médecine, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.
  • Doria A; Rheumatology Unit, Department of Medicine, University of Padova, Padova, Italy.
  • Allanore Y; Service de Rhumatologie, Hôpital Cochin, APHP, Université Paris Descartes, Paris, France.
Rheumatology (Oxford) ; 61(12): 4786-4796, 2022 11 28.
Article em En | MEDLINE | ID: mdl-35348643

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Escleroderma Sistêmico / Doenças Pulmonares Intersticiais / Esclerodermia Difusa / Esclerodermia Limitada / Hipertensão Pulmonar Tipo de estudo: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Escleroderma Sistêmico / Doenças Pulmonares Intersticiais / Esclerodermia Difusa / Esclerodermia Limitada / Hipertensão Pulmonar Tipo de estudo: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article